The Ministry of Health and Prevention (MOHAP), UAE conducted a bio therapeutics workshop on May 14, 2017 from 10 AM to 12 PM at the MOHAP main office in Dubai.
Khadeija Ahmed Saeed (MOHAP) opened the meeting and thanked the members for their presence and participation. Ameen Mohamed El Shamy (MOHAP) welcomed the members of the workshop, and mentioned that such a workshop will help to discuss in detail the specifics of biologic medications and address any concerns related to them. He added that the spectrum of therapy is becoming complex and there has been an apparent shift towards biologics in particular. The assessment of biologics and biosimilars can no longer be confined to chemical molecular structure, data from clinical trials and innovator was done by analyzing the molecule data and clinical trials. As biologic medications have a significant impact on the cost and also affects the financial budget, there is a need to identify other parameters for the effective assessment of biologics. Ameen mentioned that the workshop will also help to understand international best practices with regard to the use of biologics.